CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by equities researchers at Truist Financial from $100.00 to $120.00 in a report issued on Wednesday,Benzinga reports.

We recently compiled a list of the 10 Best Bank Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

For this list, we picked the top 10 bank dividend stocks based on their popularity among elite hedge funds in the third ...

In a report released today, Michael Ciarmoli from Truist Financial maintained a Hold rating on Curtiss-Wright (CW – Research Report). The ...

Truist Financial Corp. closed 5.45% below its 52-week high of $49.06, which the company reached on November 25th.

We ran that screen on Feb. 15 last year, using data as of the market close the previous day. Nvidia's (NVDA) stock has returned 80% from Feb. 14, 2024, through Tuesday, while the S&P 500 SPX has ...

Truist Financial Corporation ( NYSE: TFC) UBS Financial Services Conference February 11, 2025 1:00 PM ET Buddy, as I say, no rest for the weary. But obviously my energy levels are back up, because we ...

In a report released today, Neal Dingmann from Truist Financial reiterated a Buy rating on California Resources Corp (CRC – Research Report), ...

Although most stocks made forward progress in January, a few of them bucked the bigger trend for understandable reasons.

WSFS makes a move into Bucks County as part of a broader plan to fill in geographic gaps in the bank's wealth management ...